1 / 45

Pregnancy & Endocrinology

Pregnancy & Endocrinology. William Harper Hamilton General Hospital McMaster University www.drharper.ca. Objectives. Thyroid Disorders & Pregnancy Normal thyroid phsyiology & pregnancy Hypothyroidism & pregnancy Thyrotoxicosis & pregnancy Postpartum thyroid dysfunction

gillian-livingston
Download Presentation

Pregnancy & Endocrinology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pregnancy & Endocrinology William Harper Hamilton General Hospital McMaster University www.drharper.ca

  2. Objectives • Thyroid Disorders & Pregnancy • Normal thyroid phsyiology & pregnancy • Hypothyroidism & pregnancy • Thyrotoxicosis & pregnancy • Postpartum thyroid dysfunction • Diabetes & Pregnancy • Gestational DM • Type 1 & Type 2 DM & Pregnancy

  3. Case 1 • 31 year old female • Somalia  Canada 3 years ago • G2P1A0, 11 weeks pregnant • Well except fatigue • Hb 108, ferritin 7 (Fe and LT4 interaction?) • TSH 0.2 mU/L, FT4 7 pM • Started on LT4 0.05  TSH < 0.01 mU/L FT4 12 pM, FT3 2.1 pM

  4. Case 1 • How would you characterize her hypothyroidism? • What are the ramifications of pregnancy to thyroid function/dysfunction?

  5. TSH Low High FT4 & FT3 FT4 Low Low High High Central Hypothyroid 1° Thyrotoxicosis 1° Hypothyroid If equivocal 2° thyrotoxicosis RAIU TRH Stim. • Endo consult • FT3, rT3 • MRI, α-SU MRI, etc.

  6. Case 1 • GH, IGF-1 normal • LH, FSH, E2, progesterone, PRL normal for pregnancy • 8 AM cortisol 345, short ACTH test normal • MRI: normal pituitary • TGAB, TPOAB negative • Normal pregnancy, delivery, baby, lactation

  7. Thyroid & Pregnancy: Normal Physiology • Increased estrogen  increased TBG (peaks wk 15-20) • Higher total T4 & T3: • normal FT4 & FT3 if normal thyroid fn. and good assay • many automated FT4 assays underestimate true FT4 level (except Nichols equilibrium dialysis free T4 assay) • if suspect your local FT4 assay is underestimating FT4 can check total T4 & T3 instead (normal pregnant range ~ 1.5x nonpregnant) • hCG peak end of 1st trimester, hCG has weak TSH agonist effect so may cause: • slight goitre • mild TSH suppression (0.1-0.4 mU/L) in 9% of preg • mild FT4 rise in 14% of preg

  8. Thyroid & Pregnancy: Normal Physiology • Fetal thyroid starts working at 12-14 wks • T4 & T3 cross placenta but do so minimally • Cross placenta well: • MTZ > PTU • TSH-R Ab (stim or block) • ATD (PTU & MTZ): • Fetal goitre (can compress trachea after birth) • MTZ  aplasia cutis scalp defects • Other MTZ reported embryopathy: choanal atresia, esophageal atresia, tracheo-esophageal fistula • Therefore do NOT use MTZ during pregnancy, use PTU instead

  9. No TSH & FTI at end of 1st trimester as expected from hCG effect Requirement to increase LT4 dose occurred between weeks 4 -20 Despite exponential rise in estradiol throughout pregnancy (note y-axis units) TBG levels plateau at 20 wks

  10. LT4 dose requirement tied to rising TBG levels • (THBI inversely proportional to TBG level) • By 10 wks need average increase of 29% LT4 dose • By 20 wks need average increase of 48% LT4 dose • No increase of dose beyond 20 wks required

  11. * Regardless of cause of hypothyroidism (Hashimoto’s, thyroidectomy) initial LT4 dose increase is usually required early (~ week 8), before 1st prenatal visit!

  12. Thyroid & Pregnancy: Hypothyroidism • 85% will need increase in LT4 dose during pregnancy due to increased TBG levels (ave dose increase 48%) • Risks: • increased spont abort, HTN/preeclampsia, abruption, anemia, postpartum hemorrhage, preterm labour, baby SGA • Fetal neuropsychological development (NEJM, 341(8):549-555, Aug 31, 2001): • Cognitive testing of children age 7-9 • Untreated hyothyroid mothers vs. normal mothers: • Average of 7 IQ points less in children • Increased risk of IQ < 85 (19% vs. 5%) • Retrospective study, data-dredging?

  13. LT4 dose adjustment in Pregnancy:- Optimize TSH preconception (0.4 – 2.5 mU/L)- TSH at pregnancy diagnosis (~3-4 wk gestation), q1mos during 1st 20 wks and after any LT4 dose change, q2mos 20 wks to term- Instruct women to take 2 extra thyroid pills/wk (q Mon, Thurs) for 29% dose increase once pregnancy suspected (+ commercial preg test)- If starting LT4 during preg: initial dose 2 ug/kg/d and recheck TSH q4wk until euthythyroid

  14. Pregnancy: screen for thyroid dysfn ? • Universal screening not currently recommended: • ACOG, AACE, Endo Society, ATA • Controversial! • Definitely screen: • Goitre, FHx thyroid dysfn., prior postpartum thyroiditis, T1DM • Ideally, check TSH preconception: • 2.5-5.0 mU/L: recheck TSH during 1st trimester • 0.4-2.5 mU/L: do not need to recheck during preg • If TSH not done preconception do at earliest prenatal visit: • 0.1-0.4 mU/L: hCG effect (9% preg), recheck in 5wk • < 0.1 mU/L: recheck immediately with FT4, FT3, T4, T3

  15. Thyrotoxicosis & Pregnancy • Causes: • Graves’ disease • TMNG, toxic adenoma • Thyroiditis • Hydatiform mole • Gestational hCG-asscociated Thyrotoxicosis • Hyperemesis gravidarum   hCG • 60%  TSH, 50%  FT4 • Resolves by 20 wks gestation • Only Rx with ATD if persists > 20 wk

  16. Thyrotoxicosis & Pregnancy • Risks: • Maternal: stillbirth, preterm labor, preeclampsia, CHF, thyroid storm during labor • Fetal: SGA, possibly congenital malformation (if 1st trimester thyrotoxicosis), fetal tachycardia, hydrops fetalis, neonatal thyrotoxicosis

  17. Thyrotoxicosis & Pregnancy • Diagnosis difficult: • hCG effect: • Suppressed TSH (9%) +/-  FT4 (14%) until 12 wks • Enhanced if hyperemesis gravidarum: 50-60% with abnormal TSH & FT4, duration to 20 wks • FT4 assays reading falsely low • T4 elevated due to TBG (1.5x normal) • NO RADIOIODINE • Measure: • TSH, FT4, FT3, T4, T3, thyroid antibodies? • Examine: goitre? orbitopathy? pretibial myxedema?

  18. Pregnant & Suppressed TSH TSH < 0.1 TSH 0.1 – 0.4 Recheck in 5 wks FT4, FT3, T4, T3 Thyroid Ab’s Examine Still suppressed Normalizes Hyperemesis Gravidarum • Very High TFT’s: • TSH undetectable • very high free/total T4/T3 • hyperthyroid symptoms • no hyperemesis • TSH-R ab + • orbitopathy • goitre, nodule/TMNG • pretibial myxedema Don’t treat with PTU Abnormal TFT’s past 20 wk Treat Hyperthyroidism (PTU)

  19. Thyrotoxicosis & Pregnancy: Rx • No RAI ever (destroy fetal thyroid) • PTU • Start 100 mg tid, titrate to lowest possible dose • Monitor qmos on Rx: T4, T3, FT4, FT3 • TSH less useful (lags, hCG suppression) • Aim for high-normal to slightly elevated hormone levels • T4 150-230 nM, T3 3.8-4.6 nM, FT4 26-32 pM • 3rd trimester: titrate PTU down & d/c prior to delivery if TFT’s permit to minimize risk of fetal goitre • Consider fetal U/S wk 28-30 to R/O fetal goitre • If allergy/neutropenia on PTU: 2nd trimester thyroidectomy

  20. Thyrotoxicosis & Lactation • ATD generally don’t get into breast milk unless at higher doses: • PTU > 450-600 mg/d • MTZ > 20 mg/d • Generally safe • I prefer PTU > MTZ for preg  lactating • Take ATD dose just after breast-feeding • Should provide 3-4h interval before lactates again

  21. Neonatal Grave’s • Rare, 1% infants born to Graves’ moms • 2 types: Transplacental trnsfr of TSH-R ab (IgG) • Present at birth, self-limited • Rx PTU, Lugol’s, propanolol, prednisone • Prevention: TSI in mom 2nd trimester, if 5X normal then Rx mom with PTU (crosses placenta to protect fetus) even if mom is euthyroid (can give mom LT4 which won’t cross placenta) Child develops own TSH-R ab • Strong family hx of Grave’s • Present @ 3-6 mos • 20% mortality, persistant brain dysfunction

  22. Postpartum & Thyroid • 5% (3-16%) postpartum women (25% T1DM) • Up to 1 year postpartum (most 1-4 months) • Lymphocytic infiltration (Hashimoto’s) • Postpartum  Exacerbation of all autoimmune dx • 25-50% persistant hypothyroidism • Small, diffuse, nontender goitre • Transiently thyrotoxic  Hypothyroid

  23. Postpartum & Thyroid • Distinguish Thyrotoxic phase from Grave’s: • No Eye disease, pretibial myxedema • Less severe thyrotoxic, transient (repeat thyroid fn 2-3 mos) • RAI (if not breast-feeding) • Rx: • Hyperthyroid symptoms: atenolol 25-50 mg od • Hypothyroid symptoms: LT4 50-100 ug/d to start • Adjust LT4 dose for symtoms and normalization TSH • Consider withdrawal at 6-9 months (25-50% persistent hypothyroid, hi-risk recur future preg)

  24. Postpartum & Thyroid • Postpartum depression • When studied, no association between postpartum depression/thyroiditis • Overlapping symtoms, R/O thyroid before start antidepressents • Screening for Postpartum Thyroiditis HOW: TSH q3mos from 1 mos to 1 year postpartum? WHO: • Symptoms of thyroid dysfn. • Goitre • T1DM • Postpartum thyroiditis with prior pregnancy

  25. Objectives • Thyroid Disorders & Pregnancy • Normal thyroid phsyiology & pregnancy • Hypothyroidism & pregnancy • Thyrotoxicosis & pregnancy • Postpartum thyroid dysfunction • Diabetes & Pregnancy • Gestational DM • Type 1 & Type 2 DM & Pregnancy

  26. Gestational Diabetes Mellitus (GDM) • “Glucose intolerance with onset/discovery during pregnancy” • Some T2DM picked up during pregnancy • Rarely some T1DM may present during pregnancy • Prevalence higher than previously thought in Canada: • 3.5 - 3.8% non-Aboriginal (but multi-ethnic) population • 8.0 - 18.0% Aboriginal

  27. Gestational Diabetes Mellitus (GDM) • Prior “selective screening” resulted in missed cases: • Caucassians < 25 y.o. • No personal or FHx of DM • No prior infant with birth weight > 4 kg • Treatment of GDM reduces perinatal morbidity • Diagnosis GDM   maternal anxiety ? • Evidence controversial for this • Therefore all women should be screened

  28. * Presence of multiple risk factors warrants earlier screening (preconception, 1st & 2nd trimester)

  29. GDM: Morbidity

  30. GDM Treatment • CBG qid: FBS, 1-2h pc • Dietary: 3 small meals, 3 small snacks • If glycemic targets not met: Insulin • Multiple Daily Injection (MDI) best • Insulins: regular, lispro, aspart ? (still new) • No glargine (stimulates IGF-I receptors)

  31. GDM Treatment • No OHA’s, not standard of care yet. • Glyburide • Minimal crossing of placenta, 3rd trimester most organogenesis complete • 1 RCT: 404 women, mild GDM, glyburide vs. insulin, no difference in outcomes • Further study before safety established • Metformin • Retrospective cohort: •  preeclampsia & stillbirth • Bias: DM women older, more obese

  32. GDM: Labour & Postpartum • NPO during Labour: • Monitor CBG q1h, target BS 4 – 6.5 mM • Hypoglycemia (BS < 4 mM): IV D5W • Hyperglycemia (BS > 6.5 mM): IV D5W & IV insulin gtt • Postpartum: • D/C all insulin (IV and SC) • CBG in recovery: • > 10 mM  CBG qid, may need Rx for T2DM • < 10 mM  stop CBG monitoring • FBS or 2hPG in 75g OGTT within 6 mos postpartum and prior to any future planned pregnancies • Encourage: breast feeding, healthy diet, exercise to prevent future Type 2 DM, GDM • Screen for future T2DM (GDM is a risk factor)

  33. T1DM, T2DM & Pregnancy • Congenital anomalies: 2-3x increased risk • Cardiac malformations • Neural Tube Defects 1 % risk • Folate 1-4 mg/d (Prenatal vitamin 0.4-1.0 mg) • d/c ACE-I and ARBs  methyldopa, etc. • Dilated eye exam: preconception & 1st trimester • T2DM: d/c OHA  insulin • Good glycemic control prior to conception: • Prevent unplanned pregnancies: OCP or 2x barrier • Initiate MDI and qid (FBS, 2hPC) prior to preg • CSII also another option

  34. T1DM, T2DM & Pregnancy < 8.0 ?

  35. T1DM & T2DM: Labour & Postpartum • NPO during Labor: • Monitor CBG q1h, target BS 4.0 – 6.5 mM • IV D5W & IV insulin gtt (Hamilton Health Sciences Protocol) • Postpartum: • D/C all IV insulin • Insulin resistance/requirements rapidly fall during & after labor • T2DM: monitor CBG qid • Restart insulin if CBG > 10 mM • T1DM: postpartum honeymoon • CBG q1h x 4h, then q2h x 4h, then q4h • Restart MDI insulin S.C. when CBG > 10 mM • No OHA, ACE-I or ARB during breast feeding!

  36. END

More Related